A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This postmarketing study will examine the use of etoricoxib (Arcoxia®) in routine clinical
practice in France as well as the use of celecoxib (Celebrex®).